Integrated BioPharma, Inc. (INBP)
Consumer · OQX
Price as at 1 Oct 2026, 11:01 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Integrated BioPharma, Inc. trades at $0.16, which is 119% below the $0.35 our fair value estimate puts on the business. On that measure alone it screens as undervalued, though a valuation model is an argument rather than a measurement, and the market is frequently right about why something is cheap.
Our moat model scores it 10 out of 100, which is little in the way of a moat. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
About Integrated BioPharma, Inc.
Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
INBP passes 1 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
INBP peers
The largest companies in the same industry (Packaged Foods), then in the same sector.
- JBS JBS N.V.
- SAP.TO Saputo Inc.
- SJM The J. M. Smucker Company
- SFD Smithfield Foods, Inc.
- PPC Pilgrim's Pride Corporation
- CAG Conagra Brands, Inc.
- INGR Ingredion Incorporated
- A2M.AX The a2 Milk Company Limited
Every consumer company we cover is on the Consumer hub.
Common questions
Is Integrated BioPharma, Inc. (INBP) undervalued?
Against our fair value estimate of $0.35, INBP at $0.16 is 119% below fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
Where does SteadyShares get its INBP data?
Fundamentals for INBP come from company filings and exchange data, as listed on OQX; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 11:01 UTC and is delayed. Our data quality score for this company is 83/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for INBP, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.